The biopharmaceutical industry is the most rapidly growing industry in the science and technology sector owing to increasing RandD investments in biopharmaceutical drug development facilities. The global automation market in biopharmaceutical industry includes deployment of automation in biopharmaceutical academic research centers, manufacturing and research companies, clinical labs, and government approved labs.

Highlights

The global Automation in Biopharmaceutical market was valued at US$ 1106.9 million in 2022 and is anticipated to reach US$ 1588 million by 2029, witnessing a CAGR of 6.2% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

One trend in the market is continuous manufacturing. Advantages of continuous operations are well-recognized in various industries. It completes the process in a shorter time as it omits the hold steps, reduces shut down time, and reduces the labor requirement. Over the decades, upstream processing utilized this technology.”

Report Scope

This report aims to provide a comprehensive presentation of the global market for Automation in Biopharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automation in Biopharmaceutical.

The Automation in Biopharmaceutical market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Automation in Biopharmaceutical market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Automation in Biopharmaceutical companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.


By Company


Danaher

GE

PerkinElmer

Tecan Trading

Thermo Fisher Scientific

Bruker

Peak Analysis and Automation

Waters

Capsugel

RheoSense

Eirechrom

BioProcess International

Novasep


Segment by Type


Clinical Stage Automation

Drug Discovery Stage Automation


Segment by Application


Research and Development

Clinical

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Automation in Biopharmaceutical companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.